Inicio
Resultado de la búsqueda
5 búsqueda de la palabra clave 'Acute kidney injury'
Clasificado(s) por (Año de edición descendente) Refinar búsqueda Genera el flujo rss de la búsqueda
Enlace permanente de la investigación
Successful treatment of thrombotic microangiopathy associated with dengue infection: A case report and literature review / John Fredy Nieto Ríos ; Isabel Cristina Ramírez Sánchez
Título : Successful treatment of thrombotic microangiopathy associated with dengue infection: A case report and literature review Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Isabel Cristina Ramírez Sánchez, Fecha de publicación : 2018 Títulos uniformes : Transplant Infectious Disease Idioma : Inglés (eng) Palabras clave : Acute kidney injury dengue infection hemolytic uremic syndrome plasma exchange therapy thrombotic microangiopathy Resumen : Dengue infection has been associated with multiple renal complications, including glomerulonephritis, acute tubular necrosis, tubulointerstitial nephritis, and thrombotic microangiopathy (TMA), this last one being a rare complication of dengue, with only a few reported cases. TMA associated with dengue can be explained by an alteration in the activity of the enzyme ADAMTS13, leading to thrombotic thrombocytopenic purpura; or it can be secondary to direct or indirect endothelial injury by the virus, which leads to hemolytic uremic syndrome. Here, we present a case of severe TMA, not related to ADAMTS13, which was clearly associated with dengue infection. Mención de responsabilidad : John Fredy Nieto-Ríos, María Fernanda Álvarez Barreneche, Sara Catalina Penagos, Diana Carolina Bello Márquez, Lina Maria Serna-Higuita, Isabel Cristina Ramírez Sánchez Referencia : Transpl Infect Dis. 2018 Feb;20(1). DOI (Digital Object Identifier) : 10.1111/tid.12824 PMID : 29178379 En línea : https://onlinelibrary.wiley.com/doi/abs/10.1111/tid.12824 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4201 Successful treatment of thrombotic microangiopathy associated with dengue infection: A case report and literature review [documento electrónico] / John Fredy Nieto Ríos, ; Isabel Cristina Ramírez Sánchez, . - 2018.
Obra : Transplant Infectious Disease
Idioma : Inglés (eng)
Palabras clave : Acute kidney injury dengue infection hemolytic uremic syndrome plasma exchange therapy thrombotic microangiopathy Resumen : Dengue infection has been associated with multiple renal complications, including glomerulonephritis, acute tubular necrosis, tubulointerstitial nephritis, and thrombotic microangiopathy (TMA), this last one being a rare complication of dengue, with only a few reported cases. TMA associated with dengue can be explained by an alteration in the activity of the enzyme ADAMTS13, leading to thrombotic thrombocytopenic purpura; or it can be secondary to direct or indirect endothelial injury by the virus, which leads to hemolytic uremic syndrome. Here, we present a case of severe TMA, not related to ADAMTS13, which was clearly associated with dengue infection. Mención de responsabilidad : John Fredy Nieto-Ríos, María Fernanda Álvarez Barreneche, Sara Catalina Penagos, Diana Carolina Bello Márquez, Lina Maria Serna-Higuita, Isabel Cristina Ramírez Sánchez Referencia : Transpl Infect Dis. 2018 Feb;20(1). DOI (Digital Object Identifier) : 10.1111/tid.12824 PMID : 29178379 En línea : https://onlinelibrary.wiley.com/doi/abs/10.1111/tid.12824 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4201 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000815 AC-2018-102 Archivo digital Producción Científica Artículos científicos Disponible Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability / Byron Enrique Piñeres Olave
Título : Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability Tipo de documento : documento electrónico Autores : Byron Enrique Piñeres Olave, Fecha de publicación : 2016 Títulos uniformes : Critical Care Medicine Idioma : Inglés (eng) Palabras clave : Acute kidney injury critical care outcomes epidemiology pediatric intensive care units renal replacement therapy sepsis Resumen : Objectives: The prevalence of septic acute kidney injury and impact on functional status of PICU survivors are unknown. We used data from an international prospective severe sepsis study to elucidate functional outcomes of children suffering septic acute kidney injury. Design: Secondary analysis of patients in the Sepsis PRevalence, OUtcomes, and Therapies point prevalence study: acute kidney injury was defined on the study day using Kidney Disease Improving Global Outcomes definitions. Patients with no acute kidney injury or stage 1 acute kidney injury (“no/mild acute kidney injury”) were compared with those with stage 2 or 3 acute kidney injury (“severe acute kidney injury”). The primary outcome was a composite of death or new moderate disability at discharge defined as a Pediatric Overall Performance Category score of 3 or higher and increased by 1 from baseline. Setting: One hundred twenty-eight PICUs in 26 countries. Patients: Children with severe sepsis in the Sepsis PRevalence, OUtcomes, and Therapies study. Interventions: None. Measurements and Main Results: One hundred two (21%) of 493 patients had severe acute kidney injury. More than twice as many patients with severe acute kidney injury died or developed new moderate disability compared with those with no/mild acute kidney injury (64% vs 30%; p Mención de responsabilidad : Julie C Fitzgerald, Rajit K Basu, Ayse Akcan-Arikan, Ledys M Izquierdo, Byron E Piñeres Olave, Amanda B Hassinger, Maria Szczepanska, Akash Deep, Duane Williams, Anil Sapru, Jason A Roy, Vinay M Nadkarni, Neal J Thomas, Scott L Weiss, Susan Furth, Sepsis PRevalence, OUtcomes, and Therapies Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators Network Referencia : Crit Care Med. 2016 Dec;44(12):2241-2250. DOI (Digital Object Identifier) : 10.1097/CCM.0000000000002007 PMID : 27513354 En línea : https://journals.lww.com/ccmjournal/Abstract/2016/12000/Acute_Kidney_Injury_in_P [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3952 Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability [documento electrónico] / Byron Enrique Piñeres Olave, . - 2016.
Obra : Critical Care Medicine
Idioma : Inglés (eng)
Palabras clave : Acute kidney injury critical care outcomes epidemiology pediatric intensive care units renal replacement therapy sepsis Resumen : Objectives: The prevalence of septic acute kidney injury and impact on functional status of PICU survivors are unknown. We used data from an international prospective severe sepsis study to elucidate functional outcomes of children suffering septic acute kidney injury. Design: Secondary analysis of patients in the Sepsis PRevalence, OUtcomes, and Therapies point prevalence study: acute kidney injury was defined on the study day using Kidney Disease Improving Global Outcomes definitions. Patients with no acute kidney injury or stage 1 acute kidney injury (“no/mild acute kidney injury”) were compared with those with stage 2 or 3 acute kidney injury (“severe acute kidney injury”). The primary outcome was a composite of death or new moderate disability at discharge defined as a Pediatric Overall Performance Category score of 3 or higher and increased by 1 from baseline. Setting: One hundred twenty-eight PICUs in 26 countries. Patients: Children with severe sepsis in the Sepsis PRevalence, OUtcomes, and Therapies study. Interventions: None. Measurements and Main Results: One hundred two (21%) of 493 patients had severe acute kidney injury. More than twice as many patients with severe acute kidney injury died or developed new moderate disability compared with those with no/mild acute kidney injury (64% vs 30%; p Mención de responsabilidad : Julie C Fitzgerald, Rajit K Basu, Ayse Akcan-Arikan, Ledys M Izquierdo, Byron E Piñeres Olave, Amanda B Hassinger, Maria Szczepanska, Akash Deep, Duane Williams, Anil Sapru, Jason A Roy, Vinay M Nadkarni, Neal J Thomas, Scott L Weiss, Susan Furth, Sepsis PRevalence, OUtcomes, and Therapies Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators Network Referencia : Crit Care Med. 2016 Dec;44(12):2241-2250. DOI (Digital Object Identifier) : 10.1097/CCM.0000000000002007 PMID : 27513354 En línea : https://journals.lww.com/ccmjournal/Abstract/2016/12000/Acute_Kidney_Injury_in_P [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3952 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000537 AC-2016-012 Archivo digital Producción Científica Artículos científicos Disponible Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma / John Fredy Nieto Ríos ; Catalina Ocampo Kohn ; Cristian Iván García Rincón ; Kenny Mauricio Gálvez Cárdenas ; Arbey Aristizabal Álzate ; Gustavo Adolfo Zuluaga Valencia
Título : Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Cristian Iván García Rincón, ; Kenny Mauricio Gálvez Cárdenas, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2016 Títulos uniformes : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Acute kidney injury cholangiocarcinoma hemolyticuremic syndrome thrombotic microangiopathies Resumen : Gemcitabine is a medication used to treat various types of malignant neoplasms. Its association with hemolytic uremic syndrome (HUS) has been described in few cases, although these cases have resulted in mortality rates of at least 50%. We report on the case of a 25-year-old patient with cholangiocarcinoma in remission who developed microangiopathic hemolytic anemia with acute anuric renal failure after receiving 5 cycles of gemcitabine chemotherapy; this condition was consistent with HUS caused by the side effects of this drug. The administration of gemcitabine was stopped, and hemodialysis, blood transfusions, plasma exchanges, steroids, doxycycline, and rituximab were used to treat the patient. A favorable outcome was achieved; in particular, hemolysis was controlled, and renal function was completely recovered. Mención de responsabilidad : John Fredy Nieto-Ríos, Mónica Zuluaga-Quintero, Lina Maria Serna Higuita, Cristian Ivan García Rincón, Kenny Mauricio Galvez-Cárdenas, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Adriana Alejandra Florez-Vargas, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2016 Jun;38(2):255-9. DOI (Digital Object Identifier) : 10.5935/0101-2800.20160035 PMID : 27438981 Derechos de uso : CC BY En línea : http://bjn.org.br/details/1860/en-US/hemolytic-uremic-syndrome-due-to-gemcitabin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3965 Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma [documento electrónico] / John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Cristian Iván García Rincón, ; Kenny Mauricio Gálvez Cárdenas, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, . - 2016.
Obra : Brazilian Journal of Nephrology
Idioma : Inglés (eng)
Palabras clave : Acute kidney injury cholangiocarcinoma hemolyticuremic syndrome thrombotic microangiopathies Resumen : Gemcitabine is a medication used to treat various types of malignant neoplasms. Its association with hemolytic uremic syndrome (HUS) has been described in few cases, although these cases have resulted in mortality rates of at least 50%. We report on the case of a 25-year-old patient with cholangiocarcinoma in remission who developed microangiopathic hemolytic anemia with acute anuric renal failure after receiving 5 cycles of gemcitabine chemotherapy; this condition was consistent with HUS caused by the side effects of this drug. The administration of gemcitabine was stopped, and hemodialysis, blood transfusions, plasma exchanges, steroids, doxycycline, and rituximab were used to treat the patient. A favorable outcome was achieved; in particular, hemolysis was controlled, and renal function was completely recovered. Mención de responsabilidad : John Fredy Nieto-Ríos, Mónica Zuluaga-Quintero, Lina Maria Serna Higuita, Cristian Ivan García Rincón, Kenny Mauricio Galvez-Cárdenas, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Adriana Alejandra Florez-Vargas, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2016 Jun;38(2):255-9. DOI (Digital Object Identifier) : 10.5935/0101-2800.20160035 PMID : 27438981 Derechos de uso : CC BY En línea : http://bjn.org.br/details/1860/en-US/hemolytic-uremic-syndrome-due-to-gemcitabin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3965 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000553 AC-2016-028 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2016-028.pdfAdobe Acrobat PDF Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy: a systematic review and meta-analysis / Lina Maria Serna Higuita ; John Fredy Nieto Ríos ; Jorge Hernando Donado Gómez
Título : Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy: a systematic review and meta-analysis Otros títulos : El bicarbonato de sodio en comparación con solución salina isotónica para prevenir la nefropatía inducida por contraste: Una revisión sistemática y meta-análisis Tipo de documento : documento electrónico Autores : Lina Maria Serna Higuita, ; John Fredy Nieto Ríos, ; Jorge Hernando Donado Gómez, Fecha de publicación : 2015 Títulos uniformes : Colombia Médica Idioma : Inglés (eng) Palabras clave : Contrast induced nephropathy acute kidney injury sodium bicarbonate sodium chloride Resumen : Introduction: Contrast-induced nephropathy is one of the main causes of acute kidney injury and increased hospital-acquired morbidity and mortality. The use of sodium bicarbonate for nephroprotection has emerged as a preventative strategy; however, its efficacy is controversial compared to other strategies, such as hydration using 0.9% saline solution. Objective: To compare the effectiveness of sodium bicarbonate vs. hydration using 0.9% saline solution to prevent contrast-induced acute kidney injury. Methods: A systematic review of studies registered in the COCHRANE, PUBMED, MEDLINE, LILACS, SCIELO and EMBASE databases was conducted. Randomized controlled studies that evaluated the use of 0.9% saline solution vs. sodium bicarbonate to prevent contrast-induced nephropathy were included. Results: A total of 22 studies (5,686 patients) were included. Sodium bicarbonate did not decrease the risk of contrast-induced nephropathy (RD= 0.00; 95% CI= -0.02 to 0.03; p= 0.83; I2= 0%). No significant differences were found in the demand for renal replacement therapy (RD= 0.00; 95% CI= -0.01 to 0-01; I2 = 0%; p= 0.99) or in mortality (RD= -0.00; 95% CI= -0.001 to 0.001; I2 = 0%; p= 0.51). Conclusions: Sodium bicarbonate administration is not superior to the use of 0.9% saline solution for preventing contrast-induced nephropathy in patients with risk factors, nor is it better at reducing mortality or the need for renal replacement therapy. Mención de responsabilidad : Carlos Andres Zapata-Chica, Diana Bello Marquez, Lina Maria Serna-Higuita, John Fredy Nieto-Ríos, Fabian David Casas-Arroyave, Jorge Hernando Donado-Gómez Referencia : Colomb Med (Cali). 2015 Sep 30;46(3):90-103. DOI (Digital Object Identifier) : 10.25100/cm.v46i3.1925 PMID : 26600623 Derechos de uso : CC BY En línea : https://colombiamedica.univalle.edu.co/index.php/comedica/article/view/1925 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3913 Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy: a systematic review and meta-analysis = El bicarbonato de sodio en comparación con solución salina isotónica para prevenir la nefropatía inducida por contraste: Una revisión sistemática y meta-análisis [documento electrónico] / Lina Maria Serna Higuita, ; John Fredy Nieto Ríos, ; Jorge Hernando Donado Gómez, . - 2015.
Obra : Colombia Médica
Idioma : Inglés (eng)
Palabras clave : Contrast induced nephropathy acute kidney injury sodium bicarbonate sodium chloride Resumen : Introduction: Contrast-induced nephropathy is one of the main causes of acute kidney injury and increased hospital-acquired morbidity and mortality. The use of sodium bicarbonate for nephroprotection has emerged as a preventative strategy; however, its efficacy is controversial compared to other strategies, such as hydration using 0.9% saline solution. Objective: To compare the effectiveness of sodium bicarbonate vs. hydration using 0.9% saline solution to prevent contrast-induced acute kidney injury. Methods: A systematic review of studies registered in the COCHRANE, PUBMED, MEDLINE, LILACS, SCIELO and EMBASE databases was conducted. Randomized controlled studies that evaluated the use of 0.9% saline solution vs. sodium bicarbonate to prevent contrast-induced nephropathy were included. Results: A total of 22 studies (5,686 patients) were included. Sodium bicarbonate did not decrease the risk of contrast-induced nephropathy (RD= 0.00; 95% CI= -0.02 to 0.03; p= 0.83; I2= 0%). No significant differences were found in the demand for renal replacement therapy (RD= 0.00; 95% CI= -0.01 to 0-01; I2 = 0%; p= 0.99) or in mortality (RD= -0.00; 95% CI= -0.001 to 0.001; I2 = 0%; p= 0.51). Conclusions: Sodium bicarbonate administration is not superior to the use of 0.9% saline solution for preventing contrast-induced nephropathy in patients with risk factors, nor is it better at reducing mortality or the need for renal replacement therapy. Mención de responsabilidad : Carlos Andres Zapata-Chica, Diana Bello Marquez, Lina Maria Serna-Higuita, John Fredy Nieto-Ríos, Fabian David Casas-Arroyave, Jorge Hernando Donado-Gómez Referencia : Colomb Med (Cali). 2015 Sep 30;46(3):90-103. DOI (Digital Object Identifier) : 10.25100/cm.v46i3.1925 PMID : 26600623 Derechos de uso : CC BY En línea : https://colombiamedica.univalle.edu.co/index.php/comedica/article/view/1925 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3913 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000494 AC-2015-047 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2015-047.pdfAdobe Acrobat PDF Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study) / John Fredy Nieto Ríos ; Lina Maria Serna Higuita ; Fabián Alberto Jaimes Barragán
Título : Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study) Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Lina Maria Serna Higuita, ; Fabián Alberto Jaimes Barragán, Fecha de publicación : 2014 Títulos uniformes : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Acute kidney injury contrast media saline waters sodium bicarbonate Resumen : Introduction: Contrast-induced nephropathy is a common complication of radiographic procedures. Different measures have been used to avoid this damage, but the evidence is controversial. New investigations are required to clarify it. We investigated the efficacy and safety of sodium bicarbonate solution compared with sodium chloride solution to prevent contrast induced nephropathy in patients with or at risk of renal dysfunction. Methods: A prospective, single-center, randomized clinical trial conducted from May 1, 2007 to February 8, 2008. Inpatients in a tertiary center, scheduled to undergo a procedure with the nonionic radiographic contrast agent iohexol. There were 220 patients with serum creatinine levels of at least 1.2 mg/dL (106.1 µmol/L) and/or type 2 diabetics, who were randomized to receive an infusion of sodium chloride (n = 113) or sodium bicarbonate (n = 107) before and after contrast dye administration. The intervention were "A" group received 1 ml/kg/hour of normal saline solution, starting 12 hours before and continuing 12 hours after iohexol contrast. "B" group received 3 ml/kg of sodium bicarbonate solution (150 mEq/L) one hour prior to procedure and then drip rate was decreased to 1 ml/kg/hour until 6 hours post procedure. Our main outcome measure was change in serum creatinine. Results: The mean creatinine value after the procedure was 1.26 mg/dL in the saline group and 1.22 mg/dL in the bicarbonate group (mean difference: 0.036; CI 95%: -0.16 to 0.23, p = 0.865). The diagnosis of contrast-induced nephropathy, defined by increase in serum creatinine on 25% or more within 2 days after administration of radiographic contrast, was done in twelve patients (12%) in the bicarbonate group and eighth patients (7.1%) in the saline group (RR: 1.68, CI 95%: 0.72 to 3.94). Conclusion: Our investigation showed that there were no differences between normal saline solution (extended infusion) vs. bicarbonate solution for nephroprotection. Mención de responsabilidad : John Fredy Nieto-Ríos, Wílmar Arley Maya Salazar, Oscar Mauricio Santos Sánchez, Janeth Liliana Jaramillo Ortega, Jorge Ignacio García Caro, Julián Miguel Aristizabal Aristizabal, Lina Maria Serna Higuita, Álvaro García García, Fabián Alberto Jaimes Barragán Referencia : J Bras Nefrol. 2014 Jul-Sep;36(3):360-6. DOI (Digital Object Identifier) : 10.5935/0101-2800.20140051 PMID : 25317619 Derechos de uso : CC BY En línea : http://www.bjn.org.br/details/1674/en-US/prevention-of-contrast-induced-nephropa [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3833 Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study) [documento electrónico] / John Fredy Nieto Ríos, ; Lina Maria Serna Higuita, ; Fabián Alberto Jaimes Barragán, . - 2014.
Obra : Brazilian Journal of Nephrology
Idioma : Inglés (eng)
Palabras clave : Acute kidney injury contrast media saline waters sodium bicarbonate Resumen : Introduction: Contrast-induced nephropathy is a common complication of radiographic procedures. Different measures have been used to avoid this damage, but the evidence is controversial. New investigations are required to clarify it. We investigated the efficacy and safety of sodium bicarbonate solution compared with sodium chloride solution to prevent contrast induced nephropathy in patients with or at risk of renal dysfunction. Methods: A prospective, single-center, randomized clinical trial conducted from May 1, 2007 to February 8, 2008. Inpatients in a tertiary center, scheduled to undergo a procedure with the nonionic radiographic contrast agent iohexol. There were 220 patients with serum creatinine levels of at least 1.2 mg/dL (106.1 µmol/L) and/or type 2 diabetics, who were randomized to receive an infusion of sodium chloride (n = 113) or sodium bicarbonate (n = 107) before and after contrast dye administration. The intervention were "A" group received 1 ml/kg/hour of normal saline solution, starting 12 hours before and continuing 12 hours after iohexol contrast. "B" group received 3 ml/kg of sodium bicarbonate solution (150 mEq/L) one hour prior to procedure and then drip rate was decreased to 1 ml/kg/hour until 6 hours post procedure. Our main outcome measure was change in serum creatinine. Results: The mean creatinine value after the procedure was 1.26 mg/dL in the saline group and 1.22 mg/dL in the bicarbonate group (mean difference: 0.036; CI 95%: -0.16 to 0.23, p = 0.865). The diagnosis of contrast-induced nephropathy, defined by increase in serum creatinine on 25% or more within 2 days after administration of radiographic contrast, was done in twelve patients (12%) in the bicarbonate group and eighth patients (7.1%) in the saline group (RR: 1.68, CI 95%: 0.72 to 3.94). Conclusion: Our investigation showed that there were no differences between normal saline solution (extended infusion) vs. bicarbonate solution for nephroprotection. Mención de responsabilidad : John Fredy Nieto-Ríos, Wílmar Arley Maya Salazar, Oscar Mauricio Santos Sánchez, Janeth Liliana Jaramillo Ortega, Jorge Ignacio García Caro, Julián Miguel Aristizabal Aristizabal, Lina Maria Serna Higuita, Álvaro García García, Fabián Alberto Jaimes Barragán Referencia : J Bras Nefrol. 2014 Jul-Sep;36(3):360-6. DOI (Digital Object Identifier) : 10.5935/0101-2800.20140051 PMID : 25317619 Derechos de uso : CC BY En línea : http://www.bjn.org.br/details/1674/en-US/prevention-of-contrast-induced-nephropa [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3833 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000411 AC-2014-077 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
2014-077.pdfAdobe Acrobat PDF